Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells ; volume:7 ; number:1 ; day:12 ; month:9 ; year:2008 ; pages:1-12 ; date:12.2008
Molecular cancer ; 7, Heft 1 (12.9.2008), 1-12, 12.2008
- Creator
-
Dejligbjerg, Marielle
Grauslund, Morten
Litman, Thomas
Collins, Laura
Qian, Xiaozhong
Jeffers, Michael
Lichenstein, Henri
Jensen, Peter Buhl
Sehested, Maxwell
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-7-70
- URN
-
urn:nbn:de:101:1-2019073018501148588250
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dejligbjerg, Marielle
- Grauslund, Morten
- Litman, Thomas
- Collins, Laura
- Qian, Xiaozhong
- Jeffers, Michael
- Lichenstein, Henri
- Jensen, Peter Buhl
- Sehested, Maxwell
- SpringerLink (Online service)
Other Objects (12)
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice
p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands
Chromatin remodeling induced by histone deacetylase inhibitors (HDACis) in HeLa, NIH 3T3 and HepG2 cells
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity
Valproic acid and peroxisome proliferator-activated receptor δ are selective modulators of a histone deacetylase with implication for the transformed phenotype of colorectal cancer cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice
p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands
Chromatin remodeling induced by histone deacetylase inhibitors (HDACis) in HeLa, NIH 3T3 and HepG2 cells
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity
Valproic acid and peroxisome proliferator-activated receptor δ are selective modulators of a histone deacetylase with implication for the transformed phenotype of colorectal cancer cells
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice
p150 ADAR1 isoform involved in maintenance of HeLa cell proliferation
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Synthesis and characterisation of novel isoform-selective histone deacetylase inhibitors (HDACi) and HDACi-based multi-target ligands
Chromatin remodeling induced by histone deacetylase inhibitors (HDACis) in HeLa, NIH 3T3 and HepG2 cells
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
Thrombotic microangiopathy associated with Valproic acid toxicity